You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Market Movers

Insomnia drug’s side effects raise worries

The FDA will poll outside experts on Merck & Co.’s insomnia drug Wednesday.

Matt Rourke/Associated Press

The FDA will poll outside experts on Merck & Co.’s insomnia drug Wednesday.

Continue reading below

The FDA says an experimental Merck drug, suvorexant,­ helps patients fall asleep but has worrisome side effects, including suicidal thinking. The FDA said company trials showed the pill consistently worked better than a placebo. But patients taking higher doses had an eight-fold increase in daytime drowsiness that interfered with driving. Four women had to stop a driving test. And over 12 months, eight cases of suicidal thinking or behavior were reported. It’s possible the FDA will allow the drug to be used only in lower doses.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.